The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Versatile-002: Overall survival of HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma patients treated with T cell stimulating immunotherapy PDS0101 and pembrolizumab.
 
Jared Weiss
Stock and Other Ownership Interests - Achilles Therapeutics (I); Enfuego Therapeutics; Lyell Immunopharma; Merus; Nektar; Nuvalent, Inc.; rvmd; Vertex; Vesselon
Consulting or Advisory Role - Amgen; AstraZeneca; BeiGene; Catalyst Pharmaceuticals; EMD Serono; G1 Therapeutics; Gilead Sciences; Jounce Therapeutics; Merck; Nanobiotix; PDS Biotechnology
Research Funding - AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); G1 Therapeutics (Inst); Genmab (Inst); Immunicum (Inst); Inspirna (Inst); Iovance Biotherapeutics (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Nurix (Inst); PDS Biotechnology (Inst); Sumitomo Dainippon Pharma Oncology (Inst); TScan Therapeutics (Inst)
 
John Kaczmar
Stock and Other Ownership Interests - HCA Healthcare (I)
Honoraria - The Scienomics Group; Triangle Insights Group
Consulting or Advisory Role - Coherus Biosciences; EMD Serono/Merck; PDS Biotechnology; Rakuten Medical
 
Kevin Harrington
Honoraria - Abbvie (Inst); ALX Oncology (Inst); AstraZeneca (Inst); BeiGene (Inst); Bicara Therapeutics (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Exelixis (Inst); Flamingo Pharma (Inst); GlaxoSmithKline (Inst); Johnson and Johnson (Inst); Merck Serono (Inst); Merus (Inst); MSD (Inst); Nanobiotix (Inst); PDS Biotechnology (Inst); PsiVac Ltd (Inst); Replimune (Inst); Scenic Biotech
Consulting or Advisory Role - AstraZeneca (Inst); BMS (Inst); Boehringer Ingelheim (Inst); Merck Serono (Inst); MSD (Inst); Nanobiotix (Inst); Replimune (Inst)
Speakers' Bureau - BMS (Inst); Merck Serono (Inst); MSD (Inst)
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Replimune (Inst)
 
Ranee Mehra
Stock and Other Ownership Interests - GlaxoSmithKline (I)
Consulting or Advisory Role - Coherus Biosciences; Janssen Oncology; Merck KGaA
Research Funding - AstraZeneca; Merck
Travel, Accommodations, Expenses - Merck KGaA
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Francis Worden
Honoraria - Eisai; Exelixis; Merck Sharp & Dohme; Merus; PDS Biotechnology; Sun Pharma Advanced Research Company
Consulting or Advisory Role - Adlai Nortye; Coherus Biosciences; Coherus Biosciences; Exelixis; Merck; PDS Biotechnology; Sun Pharma Advanced Research Company
Research Funding - Adlai-Nordlyte; Coherus Biosciences; CUE Biopharma (Inst); EpicentRx; Loxo/Lilly (Inst); Merck (Inst); PDS Biotechnology
Travel, Accommodations, Expenses - Merck Sharp & Dohme; Sun Pharma Advanced Research Company
 
Ralph Zinner
Employment - iTEOS Therapeutics (I)
Stock and Other Ownership Interests - iTEOS Therapeutics (I)
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Anshu Giri
No Relationships to Disclose
 
Hyunseok Kang
Honoraria - Axis Medical Education; Binacea; BMJ publishing; Cancer Expert Now; Massachusetts Medical Society
Consulting or Advisory Role - Achilles Therapeutics; Bayer; Coherus Biosciences; Exelixis; GlaxoSmithKline; HLB Group; MitoImmune; PIN therapeutics; Prelude Therapeutics; Qum Therapeutics; Tempus
Research Funding - Ayala Pharmaceuticals (Inst); Elevar Therapeutics (Inst); Exelixis (Inst); Kura Oncology (Inst); Lilly (Inst); NeoImmuneTech (Inst); PDS Biotechnology (Inst); Prelude Therapeutics (Inst); Remix Therapeutics (Inst)
Other Relationship - Wiley
 
Danh Pham
No Relationships to Disclose
 
Sidra Najeeb
No Relationships to Disclose
 
Priyanka Bhateja
No Relationships to Disclose
 
Timothy Panella
No Relationships to Disclose
 
Ammar Sukari
Stock and Other Ownership Interests - Bristol-Myers Squibb/Pfizer; Immunomedics
Honoraria - Merck KGaA
Speakers' Bureau - Coherus Biosciences; MSD
 
Varinder Kaur
Research Funding - Aspyrian Therapeutics (Inst); BeiGene (Inst); Genentech (Inst); Hookipa Pharma (Inst); Merck Sharp & Dohme (Inst); PDS Biotechnology (Inst); Regeneron (Inst); SDP Pharma (Inst)
 
Jaspreet Grewal
Honoraria - Bristol-Myers Squibb/Roche; Curio Science
Consulting or Advisory Role - Castle Biosciences
Speakers' Bureau - Bristol-Myers Squibb/Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Castle Biosciences
 
David Schaaf
Employment - PDS Biotechnology
Stock and Other Ownership Interests - PDS Biotechnology; Pfizer
 
Sally Jones
Employment - PDS Biotechnology
Stock and Other Ownership Interests - PDS Biotechnology
 
Katharine Price
Consulting or Advisory Role - PDS Biotechnology
(OPTIONAL) Uncompensated Relationships - InSitu Therapeutics; InSitu Therapeutics